Yulia N Linkova

12PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceNeurology and neuromuscular diseasesAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 08, 2025
[Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis].

A N Boyko, V M Alifirova, Z A Goncharova

|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.

E L Nasonov, V I Mazurov, A M Lila

|Dec 18, 2024
[Natural history of spinal muscular atrophy type I].

D V Vlodavets, Yu N Linkova, A V Zinkina-Orikhan

|Apr 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

A N Boyko, V M Alifirova, I G Lukashevich

|Aug 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

A N Boyko, V M Alifirova, I G Lukashevich

|Apr 21, 2023
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].

A N Boyko, V M Alifirova, I G Lukashevich

Pageof 2

Frequent Collaborators

12 joint publications

Arina V Zinkina-Orikhan

7 joint publications

N A Totolyan

7 joint publications

Ye V Parshina

7 joint publications

L G Zaslavsky